Mesure d'audience ROI frequentation par
Home
Our Involvement
R&D Pipeline
Research
Inecalcitol Development
Partnering
News
Our Corporate Web Site
R&D Pipeline
Hybrigenics Pharma
News:
New Hybrigenics patent application for high-yield inecalcitol production
Hybrigenics unveils a lead chemical structure for its discovery of new anticancer drugs
Hybrigenics receives authorization
to dose prostate cancer patients
twice daily with oral inecalcitol
Investors
Contact Us
Glossary
Site Map
Legal Mentions
English
Français
© 2010 hybrigenics
